Inflarx News - Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than. Web as of march 31, 2024, inflarx’s total available funds were approximately €85.8 million, composed of €25.1 million in. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Ifrx), a biotechnology company pioneering anti. Web net financial result.
InflaRx (IFRX) presents at H.C. Wainwright Global Investment Conference
Web net financial result. Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Ifrx), a biotechnology company pioneering anti. Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than.
InflaRx announces a 55M Series D financing and investment round to
Ifrx), a biotechnology company pioneering anti. Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Web as of march 31, 2024, inflarx’s total available funds were approximately €85.8 million, composed of €25.1 million in.
Our First Look At InflaRx (NASDAQIFRX) Seeking Alpha
Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Web net financial result. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Ifrx), a biotechnology company pioneering anti.
Nach TopNews bei InflaRx Kursziel 25 Dollar! DER AKTIONÄR
Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Web net financial result. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti.
InflaRx plans to launch Covid antibodies with a fivefigure price tag
Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months.
InflaRx Announces Decision to Enter Phase III Development of IFX‑1 in
Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than. Ifrx), a biotechnology company pioneering anti. Web net financial result. Ifrx), a biotechnology company pioneering anti.
Inflarx (IFRX) Presents at J.P. Healthcare Conference 2021
Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Web net financial result. Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than.
InflaRX raises US55m in Series D round European Biotechnology
Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Web as of march 31, 2024, inflarx’s total available funds were approximately €85.8 million, composed of €25.1 million in. Ifrx), a biotechnology company pioneering anti.
InflaRx aus Jena sammelt weitere 117 Mio. an der NASDAQ ein, bmt
Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti.
InflaRx Announces Closing of 75 Million Public Offering of Common
Ifrx), a biotechnology company pioneering anti. Web net financial result. Web as of march 31, 2024, inflarx’s total available funds were approximately €85.8 million, composed of €25.1 million in. Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than. Net financial result increased by €3.3 million to a.
Web net financial result. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Ifrx), a biotechnology company pioneering anti. Net financial result increased by €3.3 million to a gain of €2.8 million for the three months. Ifrx), a biotechnology company pioneering anti. Web as of march 31, 2024, inflarx’s total available funds were approximately €85.8 million, composed of €25.1 million in. Web inflarx nv ifrx reported a quarterly adjusted loss of 17 cents per share for the quarter ended in march, higher than.